 JPMorgan Chase Co. increased its position in Flexion Therapeutics Inc NASDAQ:FLXN by 18.1 in the first quarter, according to the company in its most recent filing with the Securities Exchange Commission. The firm owned 174,912 shares of the specialty pharmaceutical companys stock after purchasing an additional 26,763 shares during the quarter. JPMorgan Chase ... 